ResearcherUniversity of DundeeActive in the last 2 years
Iain Stephen Tait
Matched on OpenAlex author ID A5110585471. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 46
2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 5
- PPARδ Expression and Prognosis in Resected Pancreatic Cancer: A Retrospective Single-Centre Study Co-author DOI 10.64898/2026.09.08.750098↗
- Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable… Co-author DOI 10.1016/s2468-1253(22)00348-x↗
- Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. Co-author DOI 10.1016/j.hpb.2021.03.003↗
- Centralization of services and reduction of adverse events in pancreatic cancer surgery. Co-author DOI 10.1007/s00268-013-2108-4↗
- Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancrea… Last author DOI 10.6092/1590-8577/519↗
Closest collaborators
The 25 strongest of 46 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Douglas J.A. Adamson · 1 shared paper, 2026 · strength 0.43
- Colin Neil Alexander Palmer · 1 shared paper, 2026 · strength 0.43
- Andreas A. Prachalias · 2 shared papers, 2021–2023 · strength 0.20
- Paper Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherap… DOI 10.1016/s2468-1253(22)00348-x↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Bilal A. Al-Sarireh · 2 shared papers, 2021–2023 · strength 0.20
- Paper Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherap… DOI 10.1016/s2468-1253(22)00348-x↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Keith John Roberts · 2 shared papers, 2021–2023 · strength 0.20
- Paper Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherap… DOI 10.1016/s2468-1253(22)00348-x↗
- Paper Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. DOI 10.1016/j.hpb.2021.03.003↗
- Yuk Ting Ma · 1 shared paper, 2023 · strength 0.12
- Paula Ghaneh · 1 shared paper, 2023 · strength 0.12
- Janet Shirley Graham · 1 shared paper, 2023 · strength 0.12
- Irfan Ahmed · 1 shared paper, 2023 · strength 0.12
- Paul J. Ross · 1 shared paper, 2023 · strength 0.12
- Markus Wolfgang Büchler · 1 shared paper, 2023 · strength 0.12
- Daniel H. Palmer · 1 shared paper, 2023 · strength 0.12
- Thilo Hackert · 1 shared paper, 2023 · strength 0.12
- Somnath Mukherjee · 1 shared paper, 2023 · strength 0.12
- Derek A O'Reilly · 1 shared paper, 2023 · strength 0.12
- Christoph Springfeld · 1 shared paper, 2023 · strength 0.12
- Kein-Leong Yim · 1 shared paper, 2023 · strength 0.12
- Long R. Jiao · 1 shared paper, 2023 · strength 0.12
- John P. Neoptolemos · 1 shared paper, 2023 · strength 0.12
- David Cunningham · 1 shared paper, 2023 · strength 0.12
- Harpreet Singh Wasan · 1 shared paper, 2023 · strength 0.12
- Juan W. Valle · 1 shared paper, 2023 · strength 0.12
- Christopher Michael Halloran · 1 shared paper, 2023 · strength 0.12
- Duncan R.C. Spalding · 1 shared paper, 2021 · strength 0.08
- James Michael Halle-Smith · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.